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Abstract
Objective: Identification and characterization of calcium-sensing receptor (CASR) mutations in four
unrelated Italian kindreds with familial hypocalciuric hypercalcemia.
Design: Clinical evaluation and genetic analysis of CASR gene. Functional characterization of mutated
CASRs.
Methods: Direct sequencing of CASR gene in genomic DNA. Studies of CASR-mediated increases in
cytosolic calcium concentration [Ca2C]i in CASR-transfected COS-7 cells in vitro.
Results: Four unreported heterozygous CASR mutations were identified, including three missense
(H595Y, P748H, and C765W) and one splice site (IVS2C1GOC) mutation. The H595Y, P748H, and
C765W mutant receptors, although expressed at normal levels on the cell surface, showed a reduced
response in [Ca2C]i relative to the wildtype (WT) CASR to increasing extracellular calcium
concentrations. Cotransfection experiments showed that the H595Y and P748H mutants did not
affect the apparent affinity of the WT CASR for calcium, suggesting that they do not exert a dominant-
negative effect. On the other hand, the co-transfected C765W mutant decreased the maximum
response of the WT CASR to calcium, suggesting that it may reduce the effective concentration of the
normal CASR on the cell surface or impair its maximal signaling capacity.
Conclusions: Four CASR mutations were identified. The reduced functional responses to extracellular
calcium and normal expression of the mutant receptors suggest that conformational changes account
for altered CASR activity. Moreover, a reduced complement of normal CASRs in these heterozygous
patients, perhaps combined with a mutant receptor-induced decrease in maximal activity of the WT
receptor, may contribute to defective calcium-sensing in vivo.
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Introduction
Familial hypocalciuric hypercalcemia (FHH) is a rare
disorder inherited as an autosomal dominant trait with
a high penetrance of over 90%, characterized by
lifelong, mild to moderate asymptomatic hypercalcemia,
relative hypocalciuria, and inappropriately normal PTH
levels (1). Patients with FHH exhibit mild to moderate
resistance of the parathyroid glands to the inhibitory
effects of Ca2C on PTH secretion, resulting in an
increase in the ‘set-point’ of Ca2C-regulated PTH
secretion (2).
The cloning of the calcium-sensing receptor (CASR)
gene has permitted clarification of the molecular basis of
FHH. The CASR is a G-protein-coupled receptor that
senses small perturbations in the level of extracellular
Ca2C [Ca2C]o and modulates the functions of para-
thyroid and kidney appropriately so as to normalize
[Ca2C]o. On the cell surface, the CASR forms disulfide-
linked dimers through cysteine residues within its
extracellular domain and the dimerization has
functional implications (3).
Heterozygous loss-of-function mutations, mainly
scattered throughout the extracellular domain of the
CASR, are responsible for most cases of FHH. The
majority of mutations are missense (4–6), with a few
nonsense (7–9) and splice site mutations (10) as well as
an Alu insertion in one family (11, 12). Functional
in vitro studies have shed light on the mechanisms
responsible for the resistance of the parathyroid gland
and kidney to calcium. Some mutations produce
receptors that do not reach the cell surface and,
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